Zevorcabtagene Autoleucel

DRUG2 trials

Sponsors

CARsgen Therapeutics Co., Ltd.

Conditions

Relapsed or Refractory Multiple MyelomaRelapsed/Refractory Multiple Myeloma

Unknown Phase

A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma

Not yet recruitingNCT06659770

CARsgen Therapeutics Co., Ltd.Relapsed/Refractory Multiple Myeloma

Start: 2024-10-31End: 2027-12-31Target: 200Updated: 2024-10-26

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

Not yet recruitingNCT06825845

CARsgen Therapeutics Co., Ltd.Relapsed or Refractory Multiple Myeloma

Start: 2025-03-31End: 2040-06-30Target: 1500Updated: 2025-02-13